Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines

By Mocellin S.   Rossi C.R.   Nitti D.   Lise M.   Marincola F.M.  

Biochimica et Biophysica Acta (BBA)/Reviews on Cancer, Vol. 1653, Iss. 2, 2003-12 ,pp. : 61-71

Elsevier

Access to resources Recommend Favorite

Novel peptide-based HIV-1 immunotherapy

By Sommerfelt Maja A   Nyhus Jørgen   Sørensen Birger  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 3, 2004-03 ,pp. : 349-361

Informa Healthcare

Access to resources Recommend Favorite

Peptide-based vaccination for colorectal cancer

By Tsuruma Tetsuhiro   Hata Fumitake   Furuhata Tomohisa   Ohmura Tosei   Katsuramaki Tadashi   Yamaguchi Koji   Kimura Yasutoshi   Torigoe Toshihiko   Sato Noriyuki   Hirata Koichi  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 6, 2005-06 ,pp. : 799-807

Informa Healthcare

Access to resources Recommend Favorite

Design and evaluation of a peptide‐based immunotoxin for breast cancer therapeutics

By  

FEBS Open Bio, Vol. 5, Iss. 1, 2015-01 ,pp. : 202-208

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?

By Dillman Robert O   Cornforth Andrew N   Nistor Gabriel  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 643-656

Informa Healthcare

Access to resources Recommend Favorite